About the World Conference on Lung Health

The Union World Conference on Lung Health is the world’s largest gathering of clinicians and public health workers, health programme managers, policymakers, researchers and advocates working to end the suffering caused by lung disease, with a focus specifically on the challenges faced by the low- and middle-income countries. Of the 10 million people who die each year from lung diseases, some 80 per cent live in these resource-limited countries.

Our theme this year, Confronting Resistance: Fundamentals to Innovations,  addresses a number of critical areas for discussion, including the growing problem of resistance to existing TB drugs, which is one of the most important challenges facing us today, while also reflecting our global tobacco control work, which requires coordinated efforts to confront resistance from the powerful tobacco industry and to introduce the innovative policies needed to de-normalise and reduce tobacco use.

Who attends

The Union World Conference attracts delegates from more than 125 countries and brings recognised global experts and opinion formers from all over the world to take part in the 150 sessions offered by the four-day scientific programme, including: 

  • Plenary sessions
  • Post-graduate courses
  • Workshops 
  • Over 60 symposia
  • Oral abstract sessions
  • Poster discussion sessions
  • E-poster discussion sessions
  • ‘Meet the expert’ sessions

Principal topics and issues

The content of the 2016 conference is categorised according to the following tracks:

  • Basic science – immunology and vaccines
  • Civil society and community engagement
  • Clinical trials for new treatments for DS-TB and MDR-TB
  • COPD, pneumonia, asthma and other lung health in adults
  • Drug-resistant TB care and treatment, except clinical trials
  • Drug-sensitive TB care and treatment, except clinical trials
  • Global Plan to End TB 2016–2020 and End TB Strategy – country-level experiences on paradigm shift
  • HIV-TB and other HIV-related lung health
  • Latent TB infection (LTBI)
  • Paediatric lung disease, including TB
  • Patient-centred care
  • TB and non-HIV comorbidities, i.e. diabetes, COPD, tobacco
  • TB diagnostics, including drug-resistance determination
  • TB education and training
  • TB epidemiology
  • TB in key affected populations
  • TB infection control
  • TB laboratory service implementation
  • TB other
  • Tobacco control
  • Zoonotic TB

The structure of the conference programme also offers ample opportunities for networking and sharing challenges and solutions.